大麻素作为一种可能的治疗子宫内膜异位症通过抑制炎症和血管生成
Roghayeh Anvari Aliabad1, Kamyab Hassanpour2, Amir Hossein Norooznezhad3
1Department of Obstetrics and Gynecology, Hamadan University of Medical Sciences, Hamadan, Iran.
Immunity, inflammation and disease
|August 7, 2024
概括
大麻 (CBD) 通过减少炎症和血管生长,对治疗子宫内膜异位症有望. 需要进一步的研究来证实其作为这种疾病治疗剂的有效性.
科学领域:
- 妇科 妇科 妇科 妇科
- 免疫学 免疫学 免疫学
- 在瘤学瘤学.
背景情况:
- 子宫内膜异位症是一种慢性炎症和血管生成的特征.
- 它的确切病原和病因仍然不清楚.
- 它与不孕症,胚胎死亡和流产有关.
研究的目的:
- 探索炎症和血管生成在子宫内膜异位症中的作用.
- 建议针对这些途径的潜在治疗方法.
- 审查Cannabidiol (CBD) 对子宫内膜异位症的治疗潜力.
主要方法:
- 审查关于子宫内膜异位症炎症和血管生成的现有文献.
- 分析特定细胞因子 (IL-1β,IL-6,TNF-α) 和血管性因素 (VEGF,HIF-1α,TGF-β1,MMPs) 的作用.
- 评估CBD的抗炎和抗血管原性质.
主要成果:
- 支持炎症的细胞因子如IL-1β,IL-6和TNF-α都与子宫内膜异位症的发病有关.
- 血管新生因素如VEGF,HIF-1α,TGF-β1和MMP在子宫内膜异位症的发展中至关重要.
- 炎症和血管新生有共同的途径,可以针对治疗.
- CBD表现出抗炎和抗血管效应,减少动物模型中的关键介质.
结论:
- CBD表现出与子宫内膜异位症相关的抗炎和抗血管原性.
- CBD可能是子宫内膜异位症的潜在治疗剂.
- 需要进一步的临床研究来验证CBD在子宫内膜异位症治疗中的疗效和安全性.
相关概念视频
01:29Drugs for Treatment of Crohn's Disease in IBD Using Immunomodulatory Agents
149
Crohn's disease is an inflammatory bowel disorder marked by chronic inflammation of the GI tract. Various treatment strategies for Crohn's disease are employed, such as immunomodulatory agents, glucocorticoids, and biologics or anti-TNF therapy. Azathioprine (Imuran), a commonly used immunomodulatory drug for Crohn's disease, is converted in the body to mercaptopurine, which inhibits purine biosynthesis and cell proliferation. Both are utilized in severe cases of Inflammatory Bowel...
149
01:29Inflammatory Bowel Disease IV: Pharmacological Management
124
Upon diagnosis, managing Inflammatory Bowel Disease (IBD) involves addressing several crucial aspects. The primary goals include resting the bowel, correcting malnutrition, and providing symptomatic relief. Resting the bowel may consist of medications to reduce inflammation and promote healing. Correcting malnutrition is essential, often requiring dietary adjustments and nutritional supplements. Symptomatic relief aims to ease pain, diarrhea, and other discomforts in IBD.
Pharmacologic...
Pharmacologic...
124
01:24Drugs for Treatment of Crohn's Disease in IBD Using Biologic Agents: Anti-TNF
124
Tumor Necrosis Factor (TNF), a proinflammatory cytokine, contributes significantly to the inflammation seen in Crohn's disease. It exists as soluble TNF and membrane-bound TNF, with actions mediated through TNF receptors (TNFR). TNFR activation leads to the release of proinflammatory cytokines, T-cell activation, collagen production, and leukocyte migration, all contributing to inflammation in Crohn's disease. Anti-TNF monoclonal antibodies, namely infliximab (Remicade), adalimumab...
124
01:17Drugs for Treatment of Diarrhea-Predominant IBS
156
Diarrhea-predominant irritable bowel syndrome (IBS-D) is a subtype of IBS characterized primarily by frequent, loose, or watery stools, abdominal pain, and abdominal discomfort. Therapeutic approaches to managing IBS-D include dietary changes, stress management techniques, and pharmaceutical interventions.
Two specific drugs used in the treatment are alosetron (Lotronex) and eluxadoline (Viberzi). Alosetron, a 5-HT3 antagonist, works by slowing the movement of stools in the gut, reducing bowel...
Two specific drugs used in the treatment are alosetron (Lotronex) and eluxadoline (Viberzi). Alosetron, a 5-HT3 antagonist, works by slowing the movement of stools in the gut, reducing bowel...
156
01:21Drugs for Treatment of Crohn's Disease in IBD Using Glucocorticoids
109
Glucocorticoids, a class of anti-inflammatory drugs, are pivotal in treating moderate to severe Crohn's disease by inducing remission. They exhibit their anti-inflammatory action by inhibiting the production of inflammatory cytokines such as tumor necrosis factor (TNF)-α, interleukin (IL)-1, and chemokines like IL-8. In addition, they reduce the expression of inflammatory cell adhesion molecules and inhibit gene transcription of nitric oxide synthase, phospholipase A2, cyclooxygenase-2...
109
02:07Oogenesis
63.6K
In human women, oogenesis produces one mature egg cell or ovum for every precursor cell that enters meiosis. This process differs in two unique ways from the equivalent procedure of spermatogenesis in males. First, meiotic divisions during oogenesis are asymmetric, meaning that a large oocyte (containing most of the cytoplasm) and minor polar body are produced as a result of meiosis I, and again following meiosis II. Since only oocytes will go on to form embryos if fertilized, this unequal...
63.6K